title: Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
authors.affiliation: Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Walsh
authors.forename: Elias J
authors.initials: EJ
authors.lastname: Anaissie
authors.forename: David W
authors.initials: DW
authors.lastname: Denning
authors.forename: Raoul
authors.initials: R
authors.lastname: Herbrecht
authors.forename: Dimitrios P
authors.initials: DP
authors.lastname: Kontoyiannis
authors.forename: Kieren A
authors.initials: KA
authors.lastname: Marr
authors.forename: Vicki A
authors.initials: VA
authors.lastname: Morrison
authors.forename: Brahm H
authors.initials: BH
authors.lastname: Segal
authors.forename: William J
authors.initials: WJ
authors.lastname: Steinbach
authors.forename: David A
authors.initials: DA
authors.lastname: Stevens
authors.forename: Jo-Anne
authors.initials: JA
authors.lastname: van Burik
authors.forename: John R
authors.initials: JR
authors.lastname: Wingard
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Patterson
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000382:microbiology / Q000628:therapy*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000188:drug therapy / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D008172:Lung Diseases, Fungal / Q000188:drug therapy / Q000382:microbiology / Q000628:therapy*
chemical_list: D000935:Antifungal Agents